Medisolv Acquires Health Elements AI to Automate Healthcare Data Abstraction
Medisolv, a healthcare quality data management company, acquired Health Elements AI on April 30 to reduce manual chart review work and expand its quality reporting capabilities. The deal brings AI-driven data abstraction technology into Medisolv's existing operations, which currently serve more than 1,800 healthcare organizations across the country.
Healthcare organizations face mounting pressure to report on quality metrics across regulatory bodies, professional associations, and value-based care payment models. Most clinical data needed for these reports still requires time-intensive manual review of medical records, creating bottlenecks in reporting and performance improvement work.
Medisolv currently works with more than 4,000 chart abstracters who reviewed nearly 3 million cases last year. The Health Elements AI platform automates parts of this work, claiming a 96 percent accuracy rate.
Scope of the Acquisition
Health Elements AI specializes in automating data abstraction for clinical registries and quality reporting. The company's platform integrates with registries from organizations including the American College of Cardiology, Society of Thoracic Surgeons, and the American Heart Association.
The acquisition expands Medisolv's reach beyond traditional CMS and accreditation programs into specialty-driven quality initiatives. Medisolv manages more than 140 million patient records across its customer base and supports over 500 quality and safety measures.
What This Means for Healthcare Organizations
The deal addresses a core operational challenge: clinical data often sits fragmented, incomplete, and difficult to access across systems. Manual abstraction slows the ability to act on that data for improvement initiatives.
By automating data capture and structuring, organizations can reduce reliance on manual review while maintaining data reliability. This frees abstracters to focus on more complex cases and allows organizations to move faster on quality improvement work.
David Lucey, Jr., CEO of Medisolv, said the acquisition helps "reduce the burden of manual chart review, make more of their clinical data usable, and build greater confidence in the information they rely on for reporting and improvement."
This acquisition follows Medisolv's purchase of Lilac Software in 2026, part of a broader strategy to modernize how healthcare organizations capture and use clinical data across quality workflows.
For professionals managing quality data and reporting, the move reflects a wider industry shift toward automating administrative tasks that have traditionally consumed significant staff time.
Your membership also unlocks:
